Jenny Rooke, founder and managing partner of Genoa Ventures (Genoa Ventures)
Q&A: How to attract the eye of an early investor in biotech R&D tools
SAN FRANCISCO — As early-stage biotechs grapple with the funding and IPO challenges associated with a down economy, some adjacent and more recession-proof areas are still …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
